Lung Treatment for Preemies Produces Uneven Results
Posted on: Thursday, 7 July 2005, 21:00 CDT
NEW YORK -- A promising lung treatment for premature babies produced mixed results -- perhaps harming some of the weakest infants, while preventing developmental problems in a healthier group, two studies show.
The treatment, inhaled nitric oxide, is safely used in full-term babies with lung problems. Doctors have been experimenting with the gas to see if it will help preemies with underdeveloped lungs who have trouble breathing.
The two studies published in today's New England Journal of Medicine differ in many ways. Company-sponsored research by the University of Chicago reported positive results in a healthier group of preemies. However, a larger, nationwide study funded by the government suggests the gas may have been harmful for much sicker, smaller infants.
Hopes for the treatment were high after a University of Chicago team reported two years ago that a small dose of nitric oxide reduced the risk of death, chronic lung disease and brain damage in a group of preemies. A two-year follow-up of the same children found those who got the gas had better mental development and fewer disabilities than those who didn't.
Study director Dr. Michael D. Schreiber said the latest results need to be confirmed "but it certainly is exciting for the possibilities."
In the larger federal study that included far sicker preemies, the nitric oxide didn't help the babies overall and the tiniest infants did worse. The results, however, suggest the gas may benefit those who weigh more than 2 pounds.
Source: Columbian
Related Articles
- New Gene Findings Will Help Guide Treatment in Infant Leukemia
- GNC Unveils Study Results for First and Only Nitric Oxide Product Clinically Proven to Improve Physical Performance at NSCA Conference in Las Vegas
- Atlas Oil and Gas Announces Results of Second Well in Pawnee County, OK
- PharmaCom BioVet, Inc. Introduces Novel Cancer Treatments in Partnership With IsoTherapeutics Group
- BioView Reports Encouraging Interim Results of Lung Cancer Diagnostic Test
- In a Phase II Study, Novartis Meningitis B Vaccine Has Potential to Produce a Protective Immune Response in Infants, the Age Group Most at Risk
- Watergy Produced Water Solutions Receives Additional Contract for Oil and Gas Produced Water Treatment
- Potential Treatment for Infant Lung Disease
- Uniting to Reduce Infant Deaths and Save Babies' Lives
- Penn Virginia Corporation Provides Third Quarter 2006 Oil and Gas Operational Results
User Comments (0)

RSS Feeds